Reviva Pharmaceuticals Holdings, Inc ARS, filed Nov 9, 2026
Reviva Pharmaceuticals Holdings, Inc. (RVPH)
Reviva Pharmaceuticals Holdings, Inc. effected a one-for-twenty reverse stock split effective March 9, 2026, then closed a public offering on March 20, 2026 that generated approximately $8.9 million in net proceeds. AI summary
ARS
2026-11-09
For: 2025-12-31
View Original
Added on
November 10, 2026